Document Detail

Non-dipping pattern in ambulatory blood pressure monitoring is associated with metabolic abnormalities in a random sample of middle-aged subjects.
MedLine Citation:
PMID:  19730439     Owner:  NLM     Status:  MEDLINE    
A reduction in the blood pressure decline at night (<10% from daytime systolic blood pressure (SBP)) during 24-h ambulatory blood pressure monitoring (ABPM) ('non-dipping pattern') is associated with cardiovascular morbidity. Our aim was to evaluate whether ABPM characteristics are associated with metabolic abnormalities in subjects without known hypertension or type 2 diabetes mellitus (T2DM). This is a cross-sectional population-based study on middle-aged subjects (n=462). Two distinct definitions of metabolic syndrome (MetS) were used: National Cholesterol Education Program-Third Adult Treatment Panel (NCEP-ATPIII) and International Diabetes Federation (IDF) criteria. Results suggested that subjects characterized by non-dipping in 24 h ABPM were more obese (P=0.014). After adjustment for body mass index, age and sex, non-dippers had higher very-low-density lipoprotein (VLDL)-cholesterol (P=0.003), total (P=0.029)-and VLDL-triglycerides (P=0.026) and oral glucose tolerance test 2 h blood glucose (P=0.027) compared with dippers. Non-dipping status was more common among subjects with MetS (P< or =0.01), impaired glucose tolerance (IGT) (P<0.05) and in those with the combination of IGT-T2DM (P< or =0.01) than among those without these abnormalities. ABPM non-dipping status was an independent predictor of IGT in multivariate models (P<0.05). With respect to MetS components, high triglycerides (P< or =0.005) and low high density lipoprotein-cholesterol (P<0.05) were associated with a non-dipping pattern. The percentage decline in blood pressure from day to night decreased with the number of metabolic abnormalities (P=0.012). In conclusion, ABPM non-dipping status is an independent predictor of glucose intolerance. It is also associated with several other metabolic abnormalities. Whether non-dipping pattern is causally related to these metabolic aberrations remains to be explored in a future prospective follow-up of this cohort.
Olavi Ukkola; Riitta-Liisa Vasunta; Y Antero Kes??niemi
Related Documents :
3291559 - Are effects of antihypertensive treatment on lipoproteins merely "side-effects"? a comp...
23728989 - The effect of aspiration pressure over endobronchial ultrasound-guided transbronchial n...
8200199 - Relationship between blood pressure and urinary albumin excretion rate in young danish ...
477699 - Systolic time intervals in middle-aged men according to smoking habits and other risk f...
11219319 - Verapamil sr and trandolapril combination therapy is safe and effective in hypertensive...
16208139 - High-density lipoprotein cholesterol levels increase with age, body mass index, blood p...
2913779 - Effects of antihypertensive therapy on blood pressure control, cognition, and reactivit...
15924399 - Pressure injection on a valved microdevice for electrophoretic analysis of submicrolite...
7935859 - Contribution by bradykinin to the natriuretic response to the angiotensin converting en...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-04
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  32     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-05     Completed Date:  2010-01-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  1022-7     Citation Subset:  IM    
Institute of Clinical Medicine, Department of Internal Medicine and Biocenter Oulu, University of Oulu, and Clinical Research Center, Oulu University Hospital, Oulu, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / metabolism
Blood Pressure / physiology*
Blood Pressure Monitoring, Ambulatory*
Circadian Rhythm / physiology
Cohort Studies
Diabetes Mellitus, Type 2 / blood
Glucose Intolerance / blood
Insulin / blood
Lipoproteins, VLDL / blood
Logistic Models
Metabolic Diseases / physiopathology*
Metabolic Syndrome X / metabolism
Middle Aged
Risk Factors
Triglycerides / blood
Reg. No./Substance:
0/Blood Glucose; 0/Lipoproteins, VLDL; 0/Triglycerides; 0/very low density lipoprotein triglyceride; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Determinants of exaggerated difference in morning and evening home blood pressure in Japanese normot...
Next Document:  Validation of automated oscillometric versus manual measurement of the ankle-brachial index.